MMP14 and COVID-19: Since we had evidence of increased expression of MMP-14 and MMP-7 in COVID-19 lung tissue by proteomics reanalysis, both described activation pathways that could be effective in TAF samples to produce active-MMP-2 and active-MMP-8.